Chemistry: analytical and immunological testing – Biospecific ligand binding assay – Utilizing isolate of tissue or organ as binding agent
Patent
1981-09-09
1984-01-17
Nucker, Christine M.
Chemistry: analytical and immunological testing
Biospecific ligand binding assay
Utilizing isolate of tissue or organ as binding agent
436825, G01N 3354, G01N 3356, G01N 3358
Patent
active
044264550
ABSTRACT:
A method of assaying for vitamin B12 achieves denaturation of serum binding proteins which normally bind the vitamin B12 by treatment with alkali at ambient temperature. The assay is characterized by the use, in the alkali denaturation step, of a dithiopolyol and cyanide, and by the use, during the intrinsic factor assay step, of a vitamin B12 analogue such as cobinamide to bind with any remaining serum proteins. The invention also includes a kit, in which the dithiopolyol is provided in admixture with the alkali.
REFERENCES:
patent: 4028465 (1977-06-01), Lewin et al.
patent: 4279859 (1981-07-01), Gutcho et al.
patent: 4332786 (1982-06-01), Cabelli et al.
Carrick David T.
Tovey Keith C.
Amersham International Limited
Nucker Christine M.
LandOfFree
Assay of vitamin B12 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Assay of vitamin B12, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Assay of vitamin B12 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-700986